04/03/2023
Ozempic pen 0.25 mg, 0.5 mg and 1 mg
Active ingredient : semaglutide
It's Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Antidiabetic Agent.
Clinical indications:
A-Type 2 diabetes:
May be used as an adjunctive agent or alternative monotherapy for patients in whom initial therapy with lifestyle intervention and metformin failed or those who cannot take metformin.
May be preferred in patients who have or are at risk for atherosclerotic cardiovascular disease
when weight loss is desired, and/or in patients with an HbA1c relatively far from goal (eg, HbA1c 9% to 10 %) .
B-Weight management:
For use as an adjunct to diet and exercise in patients with a BMI ≥30 kg/m2, or in patients with a BMI ≥27 kg/m2 and ≥1 weight-associated comorbidity (eg, hypertension, dyslipidemia).